Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Tirzepatide and semaglutide are both GLP-1 receptor agonists that help with weight loss, but they work through different pathways in your body
In June 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) called on healthcare professionals to submit Yellow Card reports on behalf of patients who develop acute pancreatitis while using GLP-1 receptor agonists
Its the active ingredient in type 2 diabetes drug Ozempic and the higher-dose obesity drug Wegovy
Clinically proven results: Patients have reported an average weight loss of 15% or more over several months
In head-to-head weight-loss trials, tirzepatide produces slightly greater weight loss than semaglutide on average
Doctor-prescribed compounded Semaglutide lose up to 1520% of body weight with once-weekly injections, delivered to your door
